Literature DB >> 31582290

Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition.

Rianne R M Engels1, Bas Israël1, Anwar R Padhani2, Jelle O Barentsz3.   

Abstract

BACKGROUND: Acquiring multiparametric magnetic resonance images of the prostate is not a simple "push-button" approach.
OBJECTIVE: To show how image acquisition of prostate multiparametric Magnetic Resonance Imaging (mpMRI) can be optimized. DESIGN, SETTING, AND PARTICIPANTS: Image protocols, magnetic field strength choice, and the use of receiver coils are discussed. In addition, patient preparation and the recognition, prevention, and mitigation of artifacts are evaluated. SURGICAL PROCEDURE: Based on expert prostate MRI technologists (MRI radiographers) opinion, the optimal protocol is reviewed, and potential artifacts are determined. MEASUREMENTS: The entire acquisition process is presented from initial patient preparation until the end of the imaging. The choice of the used equipment, pulse sequences, and prevention of patient- and imaging-related artifacts are presented. This will be shown in individual patients. RESULTS AND LIMITATIONS: Although the Prostate Imaging Reporting and Data System guidelines (2012 and 2016) describe minimal and optimal acquisition protocols for prostate mpMRI, these standards are not always met in daily practice. A major challenge in mpMRI is to obtain high image quality and reduce its variability for radiologic interpretations. A summary of evidence and guidelines for the acquisition of mpMRI of the prostate can set a basic guideline to reduce these variabilities.
CONCLUSIONS: This article and an accompanying video can be used as a guide by MRI technologists (MRI radiographers) to improve their image acquisitions by optimizing protocols, magnetic field strength choice, and use of receiver coils. We also discuss patient preparation and the recognition, prevention, and mitigation of artifacts. PATIENT
SUMMARY: In this first surgery-in-motion contribution, we will show how optimized image acquisition is performed to detect prostate cancer. Both MRI-dependent and patient related factors are discussed.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acquisition; Magnetic resonance imaging; Prostate cancer

Mesh:

Year:  2019        PMID: 31582290     DOI: 10.1016/j.eururo.2019.09.021

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

1.  Simplified PI-RADS (S-PI-RADS) for biparametric MRI to detect and manage prostate cancer: What urologists need to know.

Authors:  Michele Scialpi; Pietro Scialpi; Eugenio Martorana; Riccardo Torre; Antonio Improta; Maria Cristina Aisa; Alfredo D'Andrea; Aldo Di Blasi
Journal:  Turk J Urol       Date:  2021-05

Review 2.  Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway.

Authors:  Tristan Barrett; Maarten de Rooij; Francesco Giganti; Clare Allen; Jelle O Barentsz; Anwar R Padhani
Journal:  Nat Rev Urol       Date:  2022-09-27       Impact factor: 16.430

3.  ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.

Authors:  Maarten de Rooij; Bas Israël; Marcia Tummers; Hashim U Ahmed; Tristan Barrett; Francesco Giganti; Bernd Hamm; Vibeke Løgager; Anwar Padhani; Valeria Panebianco; Philippe Puech; Jonathan Richenberg; Olivier Rouvière; Georg Salomon; Ivo Schoots; Jeroen Veltman; Geert Villeirs; Jochen Walz; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2020-05-19       Impact factor: 5.315

4.  MRI tracing of ultrasmall superparamagnetic iron oxide nanoparticle‑labeled endothelial progenitor cells for repairing atherosclerotic vessels in rabbits.

Authors:  Hongxia Wei; Tingting Tan; Li Cheng; Jiapeng Liu; Hongyan Song; Lei Li; Kui Zhang
Journal:  Mol Med Rep       Date:  2020-08-13       Impact factor: 2.952

5.  Reproducibility of magnetic resonance fingerprinting-based T1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study.

Authors:  Nikita Sushentsev; Joshua D Kaggie; Rhys A Slough; Bruno Carmo; Tristan Barrett
Journal:  PLoS One       Date:  2021-01-29       Impact factor: 3.240

6.  Systematic sampling during MRI-US fusion prostate biopsy can overcome errors of targeting-prospective single center experience after 300 cases in first biopsy setting.

Authors:  Emanuel Cata; Iulia Andras; Matteo Ferro; Pierre Kadula; Daniel Leucuta; Gennaro Musi; Deliu-Victor Matei; Ottavio De Cobelli; Attila Tamas-Szora; Cosmin Caraiani; Andrei Lebovici; Flavia Epure; Maria Bungardean; Radu-Tudor Coman; Nicolae Crisan
Journal:  Transl Androl Urol       Date:  2020-12

7.  Prostate MRI using a rigid two-channel phased-array endorectal coil: comparison with phased array coil acquisition at 3 T.

Authors:  Sara Lewis; Aasrith Ganti; Pamela Argiriadi; Ally Rosen; Stefanie Hectors; Sahar Semaan; Christopher Song; Steve Peti; Maxwell Segall; Kezia George; Vaneela Jaikaran; Sebastian Villa; David Kestenbaum; Nicholas Voutsinas; John Doucette; Ashutosh Tewari; Ardeshir R Rastinehad; Bachir Taouli
Journal:  Cancer Imaging       Date:  2022-03-16       Impact factor: 3.909

8.  Factors Influencing Variability in the Performance of Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer: A Systematic Literature Review.

Authors:  Armando Stabile; Francesco Giganti; Veeru Kasivisvanathan; Gianluca Giannarini; Caroline M Moore; Anwar R Padhani; Valeria Panebianco; Andrew B Rosenkrantz; Georg Salomon; Baris Turkbey; Geert Villeirs; Jelle O Barentsz
Journal:  Eur Urol Oncol       Date:  2020-03-17

9.  MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance.

Authors:  Nikita Sushentsev; Leonardo Rundo; Oleg Blyuss; Vincent J Gnanapragasam; Evis Sala; Tristan Barrett
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

10.  Editorial Comment: Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy.

Authors:  Andre Luiz Lima Diniz
Journal:  Int Braz J Urol       Date:  2020 Jul-Aug       Impact factor: 1.541

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.